Bisphosphonate

A cohort of Asian adults were 3.4 times more likely to experience an atypical femur fracture compared with non-Asian adults, although the incidence was still low, according to findings published in Bone.

A baseline fracture risk should guide the selection of initial osteoporosis therapy for postmenopausal women, and treatment should be continued for as long as the expected benefits outweigh the potential risks, according to an updated guideline from the American Association of Clinical Endocrinologists and the American College of Endocrinology.

Leading bone health organizations have issued guidance for health care professionals treating people with osteoporosis during the COVID-19 pandemic, outlining important treatment adjustments for osteoporosis therapies and alternative methods for assessing fracture risk in the absence of a DXA scan.

A cross-sectional analysis of more than 1,400 men suggested that phthalate metabolites from plastics and personal care products influenced testosterone levels — a top story in endocrinology last week.

Adults with moderate to severe chronic kidney disease at high risk for fracture were no more likely to die of any cause when prescribed bisphosphonate therapy compared with adults with CKD who were not prescribed a bisphosphonate, according to findings from a population-based study published in the Journal of Bone and Mineral Research.

ATLANTA — The 2019 iteration of the ACR/ARP Great Debate tackled the issue of whether anabolic therapies are appropriate for patients with glucocorticoid-induced osteoporosis.